Literature DB >> 3343993

The muscle fiber conduction velocity and power spectra in familial hypokalemic periodic paralysis.

M J Zwarts1, T W van Weerden, T P Links, H T Haenen, H J Oosterhuis.   

Abstract

Surface EMG has been used to determine the average muscle fiber conduction velocity (MFCV) and power spectra of the m. biceps of 10 patients and 15 asymptomatic offspring of a large kinship with familial hypokalemic periodic paralysis (HOPP). The MFCV of the patients was 3.37 +/- 0.35 m/sec (mean +/- SD, n = 9), the median frequency (Fmed) of the power spectra was 55.0 +/- 5.8 Hz (mean +/- SD, n = 9), both values are significantly (P0.001, Student's t-test) lower than the control values: MFCV = 4.55 +/- 0.33 m/sec; Fmed = 88.6 +/- 15.5 Hz (mean +/- SD). In 6 of the 15 asymptomatic relatives, the surface EMG results were also abnormal. It is concluded that the MFCV is reduced in familial HOPP. This results in a predominantly low-frequency content of the power spectra, thereby providing a new model for studying the relationship between the MFCV and the frequency spectrum of surface EMG. Asymptomatic relatives that have inherited the disease probably can be detected with this method.

Entities:  

Mesh:

Year:  1988        PMID: 3343993     DOI: 10.1002/mus.880110213

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

Review 1.  Skeletal muscle sodium current is reduced in hypokalemic periodic paralysis.

Authors:  R L Ruff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  Relative contributions of central and peripheral factors to fatigue during a maximal sustained effort.

Authors:  Maartje L Schillings; Wouter Hoefsloot; Dick F Stegeman; Machiel J Zwarts
Journal:  Eur J Appl Physiol       Date:  2003-08-05       Impact factor: 3.078

3.  Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations.

Authors:  Stanislas Faguer; Dominique Chauveau; Pascal Cintas; Ivan Tack; Olivier Cointault; Lionel Rostaing; Rosa Vargas-Poussou; David Ribes
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

4.  Improvement of muscle strength in familial hypokalaemic periodic paralysis with acetazolamide.

Authors:  T P Links; M J Zwarts; H J Oosterhuis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

5.  Surface EMG and muscle fibre conduction during attacks of hypokalaemic periodic paralysis.

Authors:  T P Links; J H van der Hoeven; M J Zwarts
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

6.  Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis.

Authors:  R H Boerman; R A Ophoff; T P Links; R van Eijk; L A Sandkuijl; A Elbaz; J E Vale-Santos; A R Wintzen; J C van Deutekom; D E Isles
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

Review 7.  Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.

Authors:  Bertrand Fontaine; Emmanuel Fournier; Damien Sternberg; Savine Vicart; Nacira Tabti
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 8.  Clinical evaluation of membrane excitability in muscle channel disorders: potential applications in clinical trials.

Authors:  James C Cleland; Eric L Logigian
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

9.  The influence of force and circulation on average muscle fibre conduction velocity during local muscle fatigue.

Authors:  M J Zwarts; L Arendt-Nielsen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.